Fresenius Medical Care North America

Fresenius Medical Care North America The FME NA page is designed to engage the healthcare community in our mission. Please also contact our product support line at 1-800-227-2572.

We are the world's leading provider of products and services for individuals with renal diseases. HOUSE RULES FOR THIS PAGE
____________________________________________

Our page is not the best place to discuss your adverse events or safety issues associated with your use of our products or treatments or other companies’ products or treatments. If you, or someone you know, have possibly

experienced an adverse event while taking any Fresenius Medical Care North America product, please consult the person’s physician, pharmacist, or other healthcare professional immediately. You are also encouraged to report side effects of prescription drugs to the FDA. To do so, visit http://www.fda.gov/medwatch or call 1-800-FDA-1088. While we welcome open conversations and the sharing of relevant experiences, all participants on our social media channels are expected to follow these guidelines.
• Show respect: please feel free to express your opinion, while respecting the opinions of others.
• Use clean language: do not use profanity or abusive language.
• Keep it relevant: please only post comments or material that is on topic.
• Avoid spam: please feel free to express your opinion. We ask – for the sake of all our users – that you don’t post the same content over and over.
• Post in English.
• Be safe and remember that social media is public. We caution you to not share your full name, email address, social media handles, phone number, address, place of work, etc. as doing so is at your own risk.
• Do not misrepresent information about Fresenius Medical Care North America or any Fresenius Medical Care North America subsidiary/business in any way.
• Do not represent or speak on behalf of Fresenius Medical Care North America or any Fresenius Medical Care North America subsidiary/business without authority to do so.
• Do not post marketing and/or PR messages promoting products or services.
• Do not repeatedly post personal or offensive comments about individual Facebook users or people working at Fresenius Medical Care North America as this may be considered harassment.
• Do not provide medical advice. You may share information about your experiences. Do not play the role of a health care professional on Fresenius Medical Care’s social media channels.
• Do not post information that violates patient privacy or safety. If you have questions regarding medical advice or whether a medical treatment or product is appropriate for you or an individual patient, always seek the advice of your physician or other qualified health care provider. For more general questions, you can also contact us at: 844-898-0333 and we will appropriately direct your call. This page does not provide medical advice, and the contents are made available to you for informational purposes only.
• This page does not provide medical diagnoses or recommendations regarding medical treatment.
• This page and the content appearing on this site are not substitutes for professional medical advice, diagnosis or treatment.
• Never disregard medical advice or delay in seeking it because of something you have read on this page.
• In an emergency, call 911 or your local emergency assistance number.
• In no event will Fresenius Medical Care be liable for any decision made or action taken in reliance upon the information provided through this page. By commenting on this page, you are indicating that you have read, understand and agree to abide by the above House Rules. Fresenius Medical Care North America monitors this page and reserves the right to remove comments or discussion posts that are not in line with the House Rules or otherwise objectionable or inconsistent with the purpose of this page.

06/11/2026

Do all In-Center dialysis treatments work the same way? Not Exactly.

💡Hemodiafiltration (HDF) is an advanced In-Center dialysis therapy designed to remove a broader range of waste and toxins from your blood clearing both small and middle‑sized molecules.

🔬 Conventional hemodialysis (HD) mainly targets smaller molecules.

📊 Clinical studies show that when HDF is delivered with a high volume of additional cleaning fluid, it may support improved patient outcomes. This enhanced therapy modality is known as HighVolumeHDF¹*.

To support access to this advanced therapy in the United States, the 5008X™ CAREsystem is the first In‑Center dialysis device designed to deliver Hemodiafiltration (HDF) and HighVolumeHDF, an advanced form of HDF.

👉 Learn more about the 5008X CAREsystem and HighVolumeHDF — link available in the first comment.



Disclaimer
*The clinical studies showing the above potential outcomes with HighVolumeHDF were conducted outside of the U.S. and did not involve the 5008X™ CAREsystem. Patient experiences may vary when being treated with HighVolumeHDF therapy.
Reference
Blankenstijn PJ, et al. N Engl J Med. 2023.

06/03/2026

What if your dialysis treatment could help you stay more active and engaged in daily life?

📊 Patients treated in clinical studies with High-Volume Hemodiafiltration have reported better preserved physical abilities and mental clarity (1,2)* when compared with conventional hemodialysis.​
👨‍👩‍👧‍👦 HighVolumeHDF may also help maintain patients’ ability to participate in family and social life and reduce pain interference in daily activities (1,2)*.​

To enable delivery of this therapy in the United States, the 5008X™ CAREsystem is the first FDA-cleared In‑Center dialysis device in the U.S. designed to deliver Hemodiafiltration (HDF) and HighVolumeHDF, an advanced form of HDF.

👉 Want to learn more about the 5008X CAREsystem and HighVolumeHDF? See the first comment for the link!



*The clinical studies showing the above potential outcomes with HighVolumeHDF were conducted outside of the U.S. and did not involve the 5008X™ CAREsystem. Patient experiences may vary when being treated with HighVolumeHDF therapy.
Quality-of-life measures referenced were assessed using validated PROMIS® questionnaires in the CONVINCE Study.

1. Blankenstijn PJ, et al. N Engl J Med. 2023.
2. Rose M., et al. Kidney International. 2024.

When unexpected challenges arise, having support can make all the difference. After a severe storm caused significant da...
05/28/2026

When unexpected challenges arise, having support can make all the difference.

After a severe storm caused significant damage to Jessica’s home, she and her family were suddenly living in a hotel while navigating repairs and trying to maintain a sense of normalcy for their children.

During this difficult time, Jessica’s supervisor encouraged her to apply for the CARES Fund, Fresenius Medical Care’s employee hardship fund, which helped to provide immediate relief.

“The CARES Fund has been a blessing to me and my family when needed the most, and I am truly grateful for it,” Jessica shared. “That’s what it’s there for, to help. And if you need help, let them help.”

The support helped to cover temporary housing, replace lost food after a power outage, and provide stability while repairs were underway. Most importantly, it gave Jessica and her family peace of mind during an incredibly stressful time.

At Fresenius Medical Care, we’re people caring for people: not only for our patients, but for one another. Stories like Jessica’s reflect the care and commitment that make our culture so meaningful.

Interested in being part of a team that cares? Explore opportunities with us: Jobs.FreseniusMedicalCare.com

05/27/2026

Looking for information on High‑Volume Hemodiafiltration?

➡️Explore the new HighVolumeHDF patient information page https://bit.ly/43qz0zG

📘 Learn what HighVolumeHDF is, the potential benefits and considerations, key questions to ask your care team, and other resources.

💡 You can also find information on the 5008X™ CAREsystem—the first FDA-cleared in‑center dialysis device in the U.S. designed to deliver Hemodiafiltration (HDF) and HighVolumeHDF, an advanced form of HDF.

Your doctor and care team can help you understand whether it’s available at your center—and how you may be able to start it.

Ever wonder if in-center dialysis could feel different?Every dialysis journey is deeply personal. Listen to what Alexand...
05/20/2026

Ever wonder if in-center dialysis could feel different?
Every dialysis journey is deeply personal. Listen to what Alexander experienced with HighVolumeHDF.

“I used to feel weak and wobbly after in-center hemodialysis — sometimes I’d lose my balance. Since switching to the new therapy on the new device, I’m steadier on my feet and recover faster after treatment.”*

👉 Learn more about the 5008X CAREsystem and HighVolumeHDF — link available in the first comment.



*The statement in this content reflects the personal experiences of the interviewee and the described effects of the therapy may vary between individuals.

Home dialysis may provide more flexibility while also supporting better health outcomes. See how we can partner to suppo...
05/14/2026

Home dialysis may provide more flexibility while also supporting better health outcomes. See how we can partner to support your patients with the training they need for a successful start to home dialysis.

Learn more: https://bit.ly/3Thj8e1

05/13/2026

What if your in‑center dialysis treatment could do even more for you?
High-Volume Hemodiafiltration is designed to take your care a step further compared to conventional hemodialysis.

ℹ️ High-Volume Hemodiafiltration (HighVolumeHDF) is an advanced dialysis treatment and one of the fastest growing dialysis therapies around the world.

📊 Clinical evidence shows that when a sufficiently high volume of fluids is removed through the dialyzer with hemodiafiltration (HDF), improvement in patient outcomes may occur. This is known as HighVolumeHDF (HVHDF). Some potential patient benefits include:

✅ Preserve Quality of Life (1,2)†*
✅ Live Longer (1)†*
✅ Maintain stable blood pressure (3,4)†§‡ and reduce cramps (5,6)†§ during dialysis
✅ Improve recovery time post-dialysis (5,7)†§
✅ Lower risk of hospital stays (3,8)†§

To enable delivery of this therapy in the United States, the 5008X™ CAREsystem is the first FDA-cleared in‑center dialysis device designed to perform Hemodiafiltration (HDF) and HighVolumeHDF, an advanced form of HDF.

👉 Learn more about the 5008X CAREsystem and HighVolumeHDF — link available in the first comment.



* Based on reduced mortality risk and slower decline in Quality of Life in patients treated with HighVolumeHDF compared to standard HD
† The clinical studies showing the above potential outcomes with HighVolumeHDF were conducted outside of the U.S. and did not involve the 5008X CAREsystem. Patient experiences may vary when being treated with HighVolumeHDF therapy.
‡ HDF patients in this study were younger and had fewer co-morbidities.
§ Not all studies show the same outcome and not all patients will experience the same benefit.

References
1.Blankenstijn PJ, et al. N Engl J Med. 2023.
2.Rose M., et al. Kidney International. 2024.
3.Maduell F., et al. J Am Soc Nephrol. 2013
4.Rootjes PA et al. Kidney Int Rep. 2022
5.Karkar A., et al. Blood Purif. 2015
6.Morena M. et al. Kidney Int. 2017
7.Nenova et al Cureus. 2024
8.Zhang Y, et al. Clin J Am Soc Nephrol. 2025

Today we honor nurses across the world who show up every day with compassion, strength, and The Power of Care. We thank ...
05/12/2026

Today we honor nurses across the world who show up every day with compassion, strength, and The Power of Care. We thank you for the difference you make in our patients' lives!

05/05/2026

Did you know in-center dialysis isn’t one‑size‑fits‑all?
Patients can receive care through several different therapy options, each designed to meet different clinical needs.

In‑center dialysis therapies include:
🔷 Conventional Hemodialysis (HD)
🔷 Hemodiafiltration (HDF) and High‑Volume Hemodiafiltration, an advanced form of HDF

❓ Why does this matter?
HDF is designed to remove a broader range of waste and toxins from your blood — clearing both small and middle‑sized molecules. Conventional HD mainly targets smaller molecules.

❓ What makes HighVolumeHDF different?
Clinical studies show that when HDF is delivered with a high volume of additional cleaning fluid, it may support improved patient outcomes¹*. This enhanced therapy modality is known as HighVolumeHDF.

Now these advanced therapies are available in the US through the 5008X™ CAREsystem.

👉 Explore the 5008X CAREsystem and HighVolumeHDF — check the first comment for the link.



*The clinical studies showing the above potential outcomes with HighVolumeHDF were conducted outside of the U.S. and did not involve the 5008X™ CAREsystem.
Patient experiences may vary when being treated with HighVolumeHDF therapy.

1.Blankenstijn PJ, et al. N Engl J Med. 2023.

The Medical Education Webinar Series April 2026 presentations are now posted to the website and open for registration!Al...
03/02/2026

The Medical Education Webinar Series April 2026 presentations are now posted to the website and open for registration!

All webinars are free with contact hours available.

You can also download the April 2026 calendar: https://bit.ly/4r4H1nj

Interested in learning more? Please register here: https://bit.ly/4p12yxG

Address

920 Winter Street
Waltham, MA
02451

Telephone

+17816999000

Website

Alerts

Be the first to know and let us send you an email when Fresenius Medical Care North America posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Fresenius Medical Care North America:

Shortcuts

Share

Category